Log In
BCIQ
Print this Print this
 

Inhixa, enoxaparin

  Manage Alerts
Collapse Summary General Information
Company Shenzhen Techdow Pharmaceutical Co. Ltd.
Description biosimilar of Lovenox enoxaparin, a low molecular weight heparin (LMWH) that indirectly inhibits Factor Xa
Molecular Target Factor Xa ; Thrombin (Factor IIa) (F2)
Mechanism of ActionAnti-thrombotic/thrombolytic
Therapeutic ModalityMacromolecule: Polysaccharide
Latest Stage of DevelopmentRegistration
Standard Indication Cardiovascular (unspecified)
Indication DetailsPrevent and treat disorders related to blood clots in adults
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today